Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Samsung Pharmaceutical Co., Ltd.

Clinical trials sponsored by Samsung Pharmaceutical Co., Ltd., explained in plain language.

Samsung Pharmaceutical Co., Ltd. 001360 KRX

A pharmaceutical company involved in manufacturing and selling drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

Could a peptide drug slow Alzheimer's? large trial launches

Disease control Not yet recruiting

This Phase 3 trial tests whether a daily injection of GV1001 can slow cognitive decline in 750 people with moderate-to-severe Alzheimer's. Participants will receive either the drug or a placebo for 24 weeks. Researchers will measure changes in thinking, memory, and daily function…

Phase: PHASE3 • Sponsor: Samsung Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC